Articles Index

Chantix FAQs
Varenicline tartrate, brand name Chantix™ is a smoking cessation medication that was developed by Pfizer, Inc. In May of 2006, Chantix was approved for use by the Food and Drug Administration(FDA). In the years since however, a number of serious concerns involving changes in mood and behavior for people taking using Chantix have surfaced.

Using Chantix to Help You Quit Smoking
Varenicline tartrate is a smoking cessation drug that was discovered and developed by Pfizer, Inc. Marketed as Chantix™, it has the unique ability to partially activate sites in the brain that are affected by nicotine, as well as neutralizing the effects of nicotine should a person smoke while using this drug.

Using Chantix to Quit Smoking
When evaluating a particular quit smoking therapy, it's helpful to hear how other people have felt when using it. This list of pros and cons comes from those who have used varenicline tartrate (Chantix™) to help them quit smoking.